FDA Grants QT Imaging™ Clearance to Calculate Fibroglandular Volume of the Breast

QTscan delivers safe, accurate monitoring of breast cancer treatment NOVATO, Calif., Sept. 22, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and the ratio of FGV to...

Click to view original post